It’s easy to forget during turbulent markets that over the long haul, stocks have helped long-term investors create life-changing wealth. Even just using index funds, disciplined investors who’ve put money to work regularly in the stock market have seen their savings climb dramatically. Those who’ve identified promising niches of the market have done far better.
Marijuana stocks have gotten a lot of attention lately because of the trend toward greater acceptance and legalization of cannabis products. That reached a peak when Canada legalized recreational marijuana earlier this month, but even after a healthy pullback in cannabis stocks, longtime investors in the space have seen impressive gains. If you’d invested $10,000 in equal parts in marijuana stocks Canopy Growth (NYSE:CGC), Cronos Group (NASDAQ:CRON), and Aurora Cannabis (NYSE:ACB) on various Canadian stock exchanges three years ago, you’d be sitting on a portfolio worth more than $200,000 today. The big question now is whether these three key cannabis leaders can keep up the positive momentum…
The best-known pot stock
Canopy Growth has the strongest reputation among marijuana investors, largely because it’s gotten the most attention from the mainstream corporate world outside of the cannabis industry. Canopy has attracted two separate investments from beer giant Constellation Brands (NYSE:STZ), including a nearly $4 billion investment just a few months ago. The deal has helped raise awareness of the entire sector, and other marijuana companies have sought partnerships of their own in order to give them the cachet that Canopy Growth has.
Canopy has become a leader in the industry because of its immense production capacity, which puts it squarely at the top of the business currently. Yet Canopy isn’t content to rest on its laurels, and it’s…
Continue reading at THE MOTLEY FOOL
